XSHE
002942
Market cap402mUSD
Oct 09, Last price
17.16CNY
1D
-0.92%
1Q
18.59%
IPO
-1.72%
Name
Zhejiang XinNong Chemical Co Ltd
Chart & performance
P/E
27.96
P/S
2.41
EPS
0.61
Div yield, %
1.73%
Shrs. gr., 5y
-0.45%
Rev. gr., 5y
-0.98%
Revenues
1.11b
+15.03%
Net income
95m
+65.27%
CFO
126m
-18.59%
Dividend
Jun 05, 20260.4 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zhejiang XinNong Chemical Co.,Ltd. is a Chinese company primarily engaged in the investigation, formulation, production, and commercialization of pesticides and pharmaceutical intermediates for the domestic market. Expanding its reach globally, the firm also distributes its products to various international territories, including Southeast Asia, Europe, the United States, Australia, and Africa. Founded in 1981, its main operational base is located in Hangzhou, China.
Key people
Zhenzhen Ding
Chief Financial Officer · since 2023
Zhanqin Wang
Deputy General Manager, Director
Gang Yao
Deputy General Manager, Secretary of the Board · since 2019
Jianrong Zhang
Deputy General Manager, Director
Yuyan Pan
Director
Yuexing Xu
Director · since 2005
Qunhui Xu
Chairman of the Board, General Manager · since 2005
Hongying Zhang
Independent Director · since 2025
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||